Thursday, October 14

A Wolf in Sheep's Clothing: Actionable Cardiometabolic Rare Diseases You Might Miss

11:00 AM – 12:00 PM
PME Symposium (non-CME)

RARE LIPID DISORDERS

12:05 PM – 12:05 PM
Opening Remarks
Christie M. Ballantyne, MD
12:05 PM – 12:25 PM
Overview of Rare Forms of Severe Hypertriglyceridemia
Rebecca J Brown, MD, MHSc
12:25 PM – 12:45 PM
Overview of Rare Forms of Severe Hypercholesterolemia
Robert S. Rosenson, MD
12:45 PM – 1:15 PM
Expert Panel Discussion & Case Presentations: Lipid Disorders
Moderator: Christie M. Ballantyne, MD
Panelists: Rebecca J Brown, MD, MHSc; Robert S. Rosenson, MD
1:15 PM – 2:15 PM
Primetime CME Symposium
2:15 PM – 2:30 PM
Refresh and Recharge Break

RARE CARDIOVASCULAR DISORDERS

2:30 PM – 2:45 PM
Transthyretin Amyloyid Cardiomyopathy (ATTR-CM)
Ola Akinboboye, MD
2:45 PM – 3:00 PM
Fabry Disease
John L. Jefferies, MD
3:00 PM – 3:15 PM
Pulmonary Arterial Hypertension
3:15 PM – 3:40 PM
Expert Panel Discussion & Case Presentations: CV Disorders
Moderator: Keith C. Ferdinand, MD
Panelists: John L. Jefferies, MD; Ola Akinboboye, MD

RARE DIABETES DISORDERS

3:40 PM – 3:55 PM
Latent Autoimmune Diabetes in Adults (LADA)
3:55 PM – 4:10 PM
Maturity-Onset Diabetes of the Young (MODY)
Rochelle Naylor, MD
4:10 PM – 4:25 PM
COVID-19 and New-Onset Diabetes
Irl B.Hirsch, MD
4:25 PM – 4:45 PM
Expert Panel Discussion & Case Presentations: Diabetes Disorders
Moderator: Anne L. Peters, MD
Panelists: Irl B.Hirsch, MD; Rochelle Naylor, MD
4:45 PM – 5:00 PM
Refresh and Recharge Break

RARE OBESITY DISORDERS

5:00 PM – 5:15 PM
Alström Syndrome
5:15 PM – 5:30 PM
Other Monogenic Forms of Obesity: POMC & LEPR Deficiencies
5:30 PM – 6:00 PM
Expert Panel Discussion & Case Presentations: Obesity Disorders
Moderator: Robert H. Eckel, MD
Panelists:
6:00 PM – 6:30 PM
Refresh and Recharge Break
6:30 PM – 7:30 PM
PME Symposium (non-CME)

Friday, October 15

FDA Update and Keynote

7:00 AM – 8:00 AM
Sunrise CME Symposium
8:00 AM – 8:15 AM
Refresh and Recharge Break
8:15 AM – 9:45 AM
Opening Remarks & FDA Update and Late Breaking Trials
Moderator: Christie M. Ballantyne, MD
Presenters: Keith C. Ferdinand, MD; Robert H. Eckel, MD; Anne L. Peters, MD; Deepak L. Bhatt, MD, MPH; George L. Bakris, MD
9:45 AM – 10:15 AM
Keynote
10:15 AM – 10:45 AM
Exhibit Hall Break
10:45 AM – 11:45 AM
Primetime CME Symposium

Session I: Obesity & Lifestyle

11:45 AM – 11:50 AM
Opening Remarks
Robert H. Eckel, MD
11:50 AM – 12:10 PM
Interventions Across the Weight Continuum: The Importance of Recognizing and Addressing Pre-Obesity
Michelle Look,MD, FAAFP, ABOM
12:10 PM – 12:25 PM
Refresh and Recharge Break
12:25 PM – 1:25 PM
PME Symposium (non-CME)
1:25 PM – 1:40 PM
Refresh and Recharge Break
1:40 PM – 2:00 PM
Motivational Interviewing and Practical Strategies for Obesity Management and Patient Education
2:00 PM – 2:30 PM
Examining Nutritional Approaches to Cardiometabolic Health: Controversies and Perspectives
Kim A. Williams, Sr., MD; Stephen Devries, MD; Kevin D. Hall, PhD
2:30 PM – 3:00 PM
Exhibit Hall Break
3:00 PM – 4:00 PM
Primetime CME Symposium
4:00 PM – 4:30 PM
Physical Activity: Is There a Correct Approach?
James O. Hill, PhD; Katrina L. Piercy, PhD, RD, ACSM-CEP, FACSM; Holly R. Wyatt, MD
4:30 PM – 5:15 PM
Challenging Obesity Cases & Panel Discussion
Moderator: Robert H. Eckel, MD
Panelists: Stephen Devries, MD; Kevin D. Hall, PhD; James O. Hill, PhD; Michelle Look,MD, FAAFP, ABOM; Katrina L. Piercy, PhD, RD, ACSM-CEP, FACSM; Kim A. Williams, Sr., MD;Holly R. Wyatt, MD
5:15 PM – 6:15 PM
Welcome Reception
6:15 PM – 7:15 PM
PME Symposium (non-CME)

Saturday, October 16

Session II: Dyslipidemia/Atherosclerosis/Thrombosis

7:00 AM – 8:00 AM
PME Symposium (non-CME)
8:05 AM – 8:05 AM
Opening Remarks
Christie M. Ballantyne, MD
8:05 AM – 8:25 AM
Inflammation and Cardiovascular Disease: Lessons Learned from Clinical Trials
Paul M. Ridker, MD
8:25 AM – 8:55 AM
Controversies Related to Primary ASCVD Risk Assessment and Management
Pamela B. Morris, MD
8:55 AM – 9:15 AM
Imaging Atherosclerosis: Advances and Gaps in Knowledge
Matthew J. Budoff, MD
9:15 AM – 10:15 AM
Primetime CME Symposium
10:15 AM – 10:45 AM
Exhibit Hall Break
10:45 AM – 11:10 AM
Omega 3s, Niacin, Fibrates, High-Dose Statins and Beyond: How Do we Address Elevated Triglycerides?
Karol E. Watson, MD
11:10 AM – 12:00 PM
Challenging Lipid Management Cases & Panel Discussion
Moderator: Christie M. Ballantyne, MD
Panelists: Matthew J. Budoff, MD; Pamela B. Morris, MD; Paul M. Ridker, MD; Karol E. Watson, MD
12:00 PM – 12:15 PM
Refresh and Recharge Break
12:15 PM – 1:15 PM
PME Symposium (non-CME)
1:15 PM – 1:30 PM
Refresh and Recharge Break

Session III: Diabetes

1:30 PM – 1:30 PM
Opening Remarks
Anne L. Peters, MD
1:30 PM – 1:50 PM
Controversies About A1c, CGM, and Time in Range
Grazia Aleppo, MD, FACE, FACP
1:50 PM – 2:20 PM
Beyond Glucose Lowering: Keeping Up with The Broadened Scope of Diabetes Drugs and The Evolving Guidelines
2:20 PM – 3:20 PM
Primetime CME Symposium
3:20 PM – 3:50 PM
Exhibit Hall Break
3:50 PM – 4:10 PM
Evaluation and Treatment of Diabetic Neuropathy
Rodica Pop-Busui MD, PhD
4:10 PM – 4:30 PM
Management of CVD and CVD Risk in Patients with Type 1 Diabetes
Bernard Zinman OC, MDCM, FRCPC, FACP
4:30 PM – 5:30 PM
Multi-disciplinary Cases in T2D and Expert Panel Discussion
Moderator: Anne L. Peters, MD
Panelists: Grazia Aleppo, MD, FACE, FACP; Rodica Pop-Busui MD, PhD; Bernard Zinman OC, MDCM, FRCPC, FACP
5:30 PM – 6:30 PM
Closing Reception
6:30 PM – 7:30 PM
PME Symposium (non-CME)
Sponsored by Dexcom.

Sunday, October 17

Session IV: Hypertension/HF/Kidney

7:00 AM – 8:00 AM
PME Symposium (non-CME)
8:05 AM – 8:05 AM
Opening Remarks
George L. Bakris, MD
8:05 AM – 8:30 AM
Upcoming and Emerging Therapies for Uncontrolled Hypertension
Rajiv Agarwal, MD
8:30 AM – 8:50 AM
Resistant Hypertension
8:50 AM – 9:30 AM
Challenging HTN Cases & Expert Panel Discussion
Moderator: George L. Bakris, MD
Panelists: Rajiv Agarwal, MD
9:30 AM – 9:45 AM
Refresh and Recharge Break
9:45 AM – 10:45 AM
Primetime CME Symposium
Challenges and Advances in Diabetic Kidney Disease: Tackling the Drivers of CKD Progression in T2DM
Supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.
10:45 AM – 11:10 AM
Understanding the Evolving Spectrum of HF: From HFrEF to HFmrEF to HFpEF
11:10 AM – 11:40 AM
Updates and Perspectives: Have We Changed the Trajectory of CKD Progression?
Janet B. McGill, MD
11:40 AM – 12:00 PM
Acute Kidney Injury: When Should You Be Concerned?
Jay L. Koyner, MD
12:00 PM – 12:45 PM
Challenging HF/Kidney Cases & Expert Panel Discussion
Moderator: George L. Bakris, MD
Panelists: Jay L. Koyner, MD; Janet B. McGill, MD